| Serial Number | 97298515 |
| Word Mark | GC BIOPHARMA |
| Filing Date | Monday, March 7, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, February 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 13, 2022 |
| Description of Mark | The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the stylized wording "GC Biopharma" in dark blue; the color white is not claimed as a feature of the mark and represents background and transparent areas only. |
| Goods and Services | Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Medicated plasters; Vaccines; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Dietary and nutritional supplements |
| Indication of Colors claimed | The color(s) green, yellow, orange, red, and dark blue is/are claimed as a feature of the mark. |
| Goods and Services | Wholesale distributorships and retail store services featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Wholesale store services featuring biological preparations for medical purposes; Retail store services featuring biological preparations for medical purposes; Retail store services featuring pharmaceutical preparations for the treatment of cells; Retail store services featuring medical instruments; Retail store services featuring medical apparatus; Retail store services featuring medical genetic analyzer; Retail store services featuring electromedical diagnostic instruments; Wholesale store services featuring pharmaceutical preparations for the treatment of cells; Wholesale store services featuring medical instruments; Wholesale store services featuring medical apparatus; Wholesale store services featuring medical genetic analyzer; Wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses |
| NOT AVAILABLE | "BIOPHARMA" |
| Goods and Services | Research and development of vaccines and medicines; Research and development, laboratory and scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Conducting clinical studies of medicines for medical research purposes; Clinical research in the nature of performing biopsies for medical research; Product research and development of medical products; Conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; Testing, inspection or research of pharmaceuticals; Scientific research relating to biology; Scientific research in the field of genetic engineering; Research and development of technology for biotechnology; Scientific research in the fields of biomedicine; Laboratory research in the field of biology; Product development of cell therapy products; Drug discovery services; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of gene analysis; Medical studies, namely, medical laboratory services; Research and development of technology for medicinal chemical manufacturing; Medical research services relating to clinical data |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 11, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 11, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 11, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Green Cross Holdings Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do 16924 KR |
| Party Name | Green Cross Holdings Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do 16924 KR |
| Event Date | Event Description |
| Thursday, March 10, 2022 | NEW APPLICATION ENTERED |
| Friday, March 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 4, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, March 12, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, October 28, 2022 | ASSIGNED TO EXAMINER |
| Friday, November 4, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, November 4, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, November 4, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, November 4, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 13, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, March 16, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, January 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 16, 2023 | SOU EXTENSION 1 FILED |
| Thursday, March 16, 2023 | SOU EXTENSION 1 GRANTED |
| Saturday, March 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 17, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, January 17, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, January 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 22, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 22, 2024 | SOU EXTENSION 3 GRANTED |
| Monday, July 22, 2024 | SOU EXTENSION 3 FILED |
| Wednesday, February 5, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 5, 2025 | SOU EXTENSION 4 FILED |
| Wednesday, February 5, 2025 | SOU EXTENSION 4 GRANTED |
| Wednesday, February 5, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |